Interpace Biosciences Inc (IDXG OTCQX) stock market data APIs
$1.6628
0.01(0.6%)
as of August 14, 2026
Try our APIs with
free plan!
Interpace Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Interpace Biosciences, Inc. provides molecular diagnostic tests and pathology services for evaluating cancer risk in the United States. It offers ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier. It primarily serves physicians, cancer centers, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Prev. Close
1.6628
Open
1.6769
High
1.6865
Low
1.6037
52 wk Range
0.77-2.4
Market Cap
45 984 K
P/E Ratio
1.8444
Shares Outstanding
27 701 K
Revenue
36 144 K
EPS
0
Beta
0.606
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at €19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only €19.99
TRY NOW
Get Interpace Biosciences Inc data using free add-ons & libraries
Get Interpace Biosciences Inc Fundamental Data
Interpace Biosciences Inc Fundamental data includes:
- Net Revenue: 36 144 K
- EBITDA: 4 649 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
€
59.99
/mo.
End-of-day & Earnings data
Get Interpace Biosciences Inc Earnings data
Corporate Events Calendar & News package for
€
19.99
/mo.
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Interpace Biosciences Inc News
New
Interpace Biosciences Announces First Quarter 2026 Financial and Business Results
Q1 Revenue of $9.0 millionQ1 Income from Continuing Operations of $0.8 millionQ1 Thyroid volume year-over-year increase of 10%Q1 Thyroid revenue year-over-year increase of 12% PARSIPPANY, NJ, May 12...
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
* Interpace Biosciences press release [https://seekingalpha.com/pr/20304987-interpace-biosciences-announces-third-quarter-2025-financial-and-business-results] (OTCQX:IDXG [https://seekingalpha.com/s...
Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results
●Q3 Revenue of $8.8 million ●Q3 Cash Collections of $10.0 million ●Q3 Thyroid test volume up 12% year-over-year to record levels ●Q3 Thyroid revenue of $8.8M; up 22% year-over-year to record l...
Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting
Highlights Independent institutional experience shows archival cytology slides enabled successful molecular results in cases previously insufficient for testing by another commercially available mole...
Get Interpace Biosciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
€19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only €19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
€99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
